Blog

  • Accord Transformer & Switchgear Limited Announces H2 FY26 & FY26 Results

    Accord Transformer & Switchgear Limited Announces H2 FY26 & FY26 Results

    H2 FY26 Total Income at ₹4,259.45 Lakhs | FY26 Total Income at ₹7,035.71 Lakhs

    Ahmedabad (Gujarat) [India], June 1: Accord Transformer & Switchgear Limited, engaged in the manufacturing of transformers and electrical equipment solutions, announced its Financial Results for H2 FY26 & FY26.

    The Company continued to witness healthy business momentum during the period, supported by rising demand from the power distribution, infrastructure, industrial, and utility sectors. With a strong focus on quality manufacturing, operational efficiency, and timely execution, the Company remains well-positioned to benefit from the growing investments in India’s power and electrical infrastructure ecosystem.

    Key Financial Highlights – 

    Particulars FY26 H2 FY26
    Total Income (₹ Lakhs) 7,035.71 4,259.45
    EBITDA (₹ Lakhs) 731.10 501.34
    EBITDA Margin (%) 10.39% 11.77%
    Net Profit (₹ Lakhs) 450.43 325.33
    Net Profit Margin (%) 6.40% 7.64%

    Recent Business Updates

    • Accord Transformer & Switchgear Limited secured multiple transformer supply and work orders from domestic industrial clients, reflecting healthy demand across the power equipment and industrial infrastructure sectors.
    • The Company received an order worth approximately ₹53.50 Lakhs for transformer supply, including inverter duty transformers, strengthening its position in specialized transformer solutions.
    • Accord Transformer successfully completed the Dynamic Short Circuit Test for its 17.6 MVA inverter duty transformer at CPRI, enhancing its technical capabilities for large industrial and renewable energy projects.
    • The Company signed a strategic MoU with the Western Administrative District of Moscow focused on energy infrastructure, EPC projects, manufacturing cooperation, and technology exchange, supporting its international expansion plans.
    • The Company continues to strengthen its product portfolio across transformers, switchgear products, package substations, and EV charging infrastructure solutions catering to renewable energy, utilities, industrial, and infrastructure sectors.

    Management Commentary

    Commenting on the performance, Mr. Pradeep Kumar Verma, Founder & Managing Director of Accord Transformer & Switchgear Limited, stated: “FY26 was an important year for Accord Transformer & Switchgear as we strengthened our market presence, expanded customer relationships, and achieved key operational milestones. During the year, we enhanced our manufacturing capabilities and continued to build momentum across transformers and power infrastructure solutions. With increasing investments in power transmission, distribution, renewable energy, and industrial infrastructure, we believe the Company is well positioned to participate in the sector’s long-term growth opportunities.”

    About Accord Transformer & Switchgear Limited

    Accord Transformer & Switchgear Limited is engaged in the manufacturing of transformers and electrical equipment solutions catering to power utilities, industrial customers, and infrastructure projects. The Company focuses on delivering quality products, operational efficiency, and reliable solutions to support India’s growing power infrastructure requirements.

    Disclaimer: Certain statements in this document that are not historical facts are forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local political or economic developments, technological risks, and many other factors that could cause actual results to differ materially from those contemplated by the relevant forward-looking statements. The Company will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.

  • Diagnoses, Tips and Care for Dengue amid Monsoon Surge

    Diagnoses, Tips and Care for Dengue amid Monsoon Surge

    New Delhi [India], June 01: At the peak of this monsoon season, health experts are highly recommending citizens to stay alert as the cases of dengue fever are increasing across the region. The steep rise in stagnant water areas, garbage dumps, and other unhygienic places results in a major source of mosquito breeding grounds. This particularly makes the monsoon season of the year dangerous, with the risk of mosquito-borne illnesses. Early and accurate diagnosis with timely medical care of dengue is crucial to avoid life-threatening situations and other complications.

    Dengue fever is caused by a mosquito named Aedes Aegypti and represents symptoms that can be easily mistaken for other viral infections. While ignorance and relying on temporary relief worsen the condition, timely testing and medical attention can save one from the prevailing consequences. 

    According to the experts of Dr. Sharda Ayurveda,“Alter your diet, enhance your immunity, eat healthy, stay hygienic, and adopt some simple steps to safeguard yourself from increasing waterborne diseases. This will turn the monsoon season into a happy and carefree time full of enjoyment.”

    Renowned Ayurvedic hospital, Dr. Sharda Ayurveda, and its experts are highly experienced and share a few tips to prevent, diagnose, and care for the disease, dengue. 

    Key tips for diagnosing dengue early 

    The global dengue situation is worsening with each passing year, recording 14.1 million dengue cases in 2024. These figures cross last year’s records by 7 million. Dengue is caused by one of the four dengue viruses, which typically lasts between 8-10 days. The first step in diagnosing dengue is to observe the early symptoms that arise in the body. These are:

    • Sudden High Fever (104⁰F/40°C)
    • Severe Headache
    • Pain in the eyes
    • Muscle & joint pain 
    • Skin rashes are visible after 2-5 days of fever
    • Nausea & Vomiting
    • Loss of appetite

    With the onset of these symptoms, one needs to be careful about health. The next step is to accurately diagnose the severity of the condition. For this, there are some specific tests required, especially during the early stages:

    • NS1 Antigen Test (within the first week of symptoms)
    • IgM and IgG Antibody Tests (from day 5 onward)
    • CBC (Complete Blood Count) to monitor platelet levels 

    Precautions to Prevent Dengue

    Here are some of the tips and precautions required to keep you and your loved ones away from dangerous mosquito-borne fever during the monsoon season. 

    1. Eliminate Stagnant Water: As this is the primary source of mosquito breeding, remove all such origins from the surroundings. Majorly, these include water coolers, flower pots, buckets, dustbins, and open drains etc. 
    1. Clean Water Storage: Water storage in and around the house, including tanks, big containers, or buckets, must be frequently cleaned and covered to prevent mosquito production. 
    1. Frequently check surroundings: One needs to be attentive and check regularly the areas where water can accumulate. These are the gutters, drains, pits, and plant saucers.
    1. Install Protective Measures: Another major change initiated during the monsoon season is to install mosquito sleeping nets. Also, ensure the doors and windows are protected to keep the mosquitoes out of the house.
    1. Maintain Clean Surroundings: A clean and tidy environment ensures no harmful mosquitoes are around. Therefore, initiate steps towards maintaining hygiene at home, office, and other public surroundings. Another step for cleanliness is to dispose of the garbage properly and avoid the dumping areas if nearby, as they create potential breeding sites. 

    Care required during Dengue Fever

    Though dengue fever is not contagious but basic care, treatment, and medication are a must for the person with it. Ayurveda focuses on balancing the tridoshas and enhancing immunity to fight against this fever. Some of the steps required for dengue fever care are:

    1. Rest: A crucial step towards recovery. Focus on complete rest as long as the symptoms persist.
    1. Hydration: Drink plenty of fluids, including juices, soups, coconut water, etc., to prevent dehydration and excess body weakening.
    1. Diet: Eat a well-balanced and healthy diet that is easy to digest. Ensure small and frequent meals to avoid an upset stomach.
    1. Herbal Remedies: Best herbs to tackle dengue fever are giloy, spirulina, wheat grass, papaya leaves, tulsi, amla, etc. One can incorporate it every day in the form of juice,  herbal tea, or capsules for better results. 

    Conclusion

    As the monsoon season also brings the risk of a dengue outbreak, early diagnosis remains a crucial step in controlling the disease. Recognising the warning signs and symptoms like headache, high fever, muscle pain, etc., requires immediate medical attention to avoid further consequences. For altered personalized treatment plans and root cause recovery, you can contact Dr. Sharda Ayurveda. With herb-based medication, a healthy diet, and lifestyle, one can get rid of such illnesses easily. 

    For inquiries or appointments, please contact:

    Dr. Sharda Ayurveda

    Website:www.drshardaayurveda.com

    Email: info@drshardaayurveda.com

    Follow on Instagram, Facebook, and YouTube for daily wellness tips

  • BigBloc Construction Ltd Reports Revenue from Operations of Rs. 283.42 crore in FY26, a rise of 26.2 Percent Y-o-Y

    BigBloc Construction Ltd Reports Revenue from Operations of Rs. 283.42 crore in FY26, a rise of 26.2 Percent Y-o-Y

    EBITDA in FY26 stood at Rs. 22.93 crore, reflecting stable performance.

    Surat (Gujarat) [India], June 1: BigBloc Construction Limited, one of the largest manufacturers of Aerated Autoclaved Concrete (AAC) Blocks, Bricks and ALC Panels in India, reported consolidated Revenue from Operations of Rs. 283.42 crore for FY26 ended March 2026, registering a robust growth of 26.2% Y-o-Y compared to Rs. 224.64 crore reported in FY25. The company reported EBITDA of Rs. 22.93 crore during FY26 with an EBITDA margin of 8.09%, reflecting stable performance despite continued pressure in the building materials sector. The margins and profitability were primarily impacted by sector-wide challenges arising from geopolitical tensions and ongoing expansion.

    Highlights:

    • Q4 FY26: Revenue from Operations Rs. 86.93 crore up 34.6% Y-o-Y, EBITDA Rs. 7.06 crore
    • FY26: Revenue from Operations Rs. 283.42 crore up 26.2% Y-o-Y, EBITDA Rs. 22.93 crore
    • Foray in construction chemicals: Commenced commercial production at Umargaon facility manufacturing products including Block Jointing Mortar, Ready Mix Plaster, and Tile Adhesives
    • Merger Approved – Hon’ble Regional Director vide order dated 28th April 2026 sanctioned the amalgamation scheme, Starbigbloc Building Material Ltd with Bigbloc Building Elements Pvt.
    • Sustainability – Company has installed 3340 KW of rooftop solar power capacity for captive use across BigBloc and its subsidiaries

    The consolidated capacity utilization for Q4 FY26 was 78%. Capacity utilization at Bigbloc Building Elements Pvt. Ltd was 89%, while Siam Cement Bigbloc Construction Technologies Pvt. Ltd reported capacity utilization of 40% during the quarter.

    The company reported consolidated Revenue from Operations of Rs. 86.93 crore for Q4 FY26 ended March 2026, registering a robust growth of 34.6% Y-o-Y compared to Rs. 64.59 crore reported in Q4 FY25. The company reported EBITDA of Rs. 7.06 crore during Q4 FY26.

    Commenting on the company’s performance, Mr. Mohit Saboo, Director & CFO, BigBloc Construction Ltd said, “The Company delivered healthy growth in revenue during the quarter and FY26 backed by improved operational efficiencies and steady demand across key markets. During the year, we strengthened our business through expansion into the construction chemicals segment, and continued focus on sustainable operations. With increasing adoption of sustainable building materials in India, we remain confident about long-term growth opportunities and will continue to focus on operational excellence, capacity expansion, and value creation for stakeholders.”

    Incorporated in 2015, BigBloc Construction Ltd is one of the largest and only listed companies in the AAC Block Space with an installed capacity of 1.3 million cubic meters per annual capacity across plants in Gujarat (Kheda, Umargaon, Kapadvanj) and Maharashtra (Wada). The company recently purchased approx. 57,500 sq. mts. of land to set up India’s largest greenfield facility for AAC Blocks in Indore, MP. BigBloc Constructions Ltd is among very few companies in the AAC industry to generate carbon credits.

    During the year, the company commenced commercial production of construction chemicals at its Umargaon facility. The plant manufactures Block Jointing Mortar, Ready Mix Plaster, and Tile Adhesives, strengthening the company’s presence in fast-growing building material segments and expanding its product portfolio.

    StarBigBloc Building Material Ltd, a subsidiary of BigBloc Construction Ltd, has now secured all key approvals for its Indore greenfield project, including Town Planning Clearance, land registration, Gram Panchayat approval, and NA order.

    Pursuant to the scheme of amalgamation approved by the Hon’ble Regional Director on April 28, 2026, Starbigbloc Building Material Ltd (SBML) has been merged with Bigbloc Building Elements Pvt. Ltd (BBEPL) effective from April 1, 2025. The restructuring is aimed at streamlining operations, improving efficiency, and strengthening the overall corporate structure. Since both entities were already consolidated within the group, the merger has no impact on the Group’s consolidated assets, liabilities, revenues, or expenses. Following the approved share swap arrangement, the company’s holding in BBEPL stands revised from 100% to 92.63%. Consequently, the non-controlling interest has been rationalized from 14.85% in SBML to 7.37% in the merged BBEPL entity.

    On the sustainability front, the total installed rooftop solar power capacity across BigBloc and its subsidiaries now stands at 3340 KW. The company has also launched its ESG Profile on ESG World, reaffirming its commitment to global sustainability standards, transparency, and responsible business practices. The profile, accessible through the Sustainability section of the company’s website, enables investors, analysts, ESG rating agencies, and financial institutions to track performance across key ESG metrics aligned with global frameworks.

    About BigBloc Construction:

    Incorporated in 2015, BIGBLOC Construction Ltd is one of the largest and only listed AAC block manufacturers in India, with a 1.3 million CBM annual capacity across plants in Gujarat (Kheda, Umargaon, Kapadvanj) and Maharashtra (Wada). The company, which markets its products under the ‘NXTBLOC’ brand, is one of the few in the AAC industry to generate carbon credits. With over 2,000 completed projects and 1,500+ in the pipeline, the company’s clients include Lodha, Adani Realty, IndiaBulls Real Estate, DB Realty, Prestige, Piramal, Oberoi Realty, Tata Projects, Shirke Group, Shapoorji Pallonji Group, Raheja, PSP Projects, L&T, Sunteck, Dosti Group, Purvankara Ltd, DY Patil, Taj Hotels, Godrej Properties, Torrent Pharma, GAIL among others.

    For more details, please visit: www.bigbloc.in

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • Unihealth Hospitals Records Stellar FY26 Growth, driven by 35% Revenue Growth and 68% Jump in Profit

    Unihealth Hospitals Records Stellar FY26 Growth, driven by 35% Revenue Growth and 68% Jump in Profit

    Mumbai (Maharashtra) [India], June 1: Unihealth Hospitals Limited (NSE: UNIHEALTH | INE0PRF01011), a rapidly expanding healthcare platform with operations across India and East Africa, today announced its audited financial results for H2 FY26 and FY26. The Company delivered another year of strong growth, marked by robust revenue expansion, improving profitability, strategic capacity additions, and significant progress on its long-term vision of building an integrated healthcare ecosystem across underserved and high-growth markets.

    Driven by rising patient volumes, increasing demand for specialized healthcare services, operational efficiencies, and successful expansion initiatives, Unihealth continues to strengthen its position as a differentiated healthcare provider focused on delivering quality, affordable, and accessible healthcare.

    H2 FY26 Consolidated Key Financial Highlights

    • Total Income of ₹67.45 Cr, YoY growth of 18.44%
    • EBITDA of ₹24.20 Cr, YoY growth of 7.26%
    • EBITDA Margin of 35.88%, YoY decline of 374 Bps
    • *Net Profit of ₹10.72 Cr, YoY growth of 19.04%
    • Net Profit Margin of 15.90%, YoY growth of 8 Bps
    • Diluted EPS of ₹6.86, YoY growth of 17.26%

    FY26 Consolidated Key Financial Highlights

    • Total Income of ₹137.01 Cr, YoY growth of 34.61%
    • EBITDA of ₹58.82 Cr, YoY growth of 48.91%
    • EBITDA Margin of 42.93%, YoY growth of 412 Bps
    • *Net Profit of ₹25.83 Cr, YoY growth of 82.87%
    • Net Profit Margin of 18.85%, YoY growth of 498 Bps
    • Diluted EPS of ₹16.52, YoY growth of 80.15%
       
       *Net Profit for the period reflects only the portion attributable to the owners of the Company.

    H2 FY26 Standalone Key Financial Highlights

    • Total Income of ₹7.70 Cr, YoY growth of 102.29%
    • EBITDA of ₹5.32 Cr, YoY growth of 186.41%
    • EBITDA Margin of 69.05%, YoY growth of 2,028 Bps
    • Net Profit of ₹3.77 Cr, YoY growth of 214.62%
    • Net Profit Margin of 48.92%, YoY growth of 1,747 Bps
    • Diluted EPS of ₹2.46, YoY growth of 211.39%

    FY26 Standalone Key Financial Highlights

    • Total Income of ₹13.23 Cr, YoY growth of 92.54%
    • EBITDA of ₹9.17 Cr, YoY growth of 158.16%
    • EBITDA Margin of 69.34%, YoY growth of 1,763 Bps
    • Net Profit of ₹6.49 Cr, YoY growth of 176.32%
    • Net Profit Margin of 49.07%, YoY growth of 1,488 Bps
    • Diluted EPS of ₹4.15, YoY growth of 171.24%

    The strong performance underscores the scalability of Unihealth’s business model, which combines hospital operations with healthcare consultancy, medical value travel, pharmaceutical exports, and healthcare infrastructure development. This diversified approach enables the Company to capture multiple opportunities across the healthcare value chain while creating sustainable long-term growth.

    Building a Cross-Border Healthcare Platform

    Over the past decade, Unihealth has evolved from a healthcare services company into a multi-dimensional healthcare enterprise with a growing presence across emerging markets. Today, the Company operates an integrated healthcare network that serves patients across India and East Africa, regions characterized by growing populations, increasing healthcare awareness, rising disposable incomes, and significant demand-supply gaps in quality healthcare infrastructure.

    The Company’s strategy focuses on establishing high-quality tertiary and specialty healthcare facilities in underserved markets while leveraging Indian medical expertise, global clinical standards, and localized partnerships. This model enables Unihealth to deliver world-class healthcare outcomes while maintaining affordability and accessibility for patients.

    With more than 600 employees and an expanding network of healthcare professionals, Unihealth continues to build a healthcare platform designed to address both current healthcare needs and future demand across its operating geographies.

    Transformational Year of Expansion

    Major milestones during FY26 were the successful commissioning of UMC Hospitals, Navi Mumbai (India), finalizing the lease for the 200-bedded UMC Hospital in Nashik (India) and the acquisition and commissioning of UMC Hospital, Entebbe, Uganda. These strategic additions significantly strengthen Unihealth’s footprint and reflect the Company’s commitment to building a leading healthcare network in high-growth markets across India and Africa.

    These transactions increased Unihealth’s overall bed capacity from 200 beds at the start of FY26 to 400 beds, substantially enhancing its ability to serve growing patient demand. 

    Beyond financial performance and expansion, Unihealth remains focused on advancing clinical outcomes and improving patient experiences. During FY26, the Company achieved a significant milestone with the first successful IVF twin birth at UMC Victoria Hospital in Uganda, marking an important achievement for its IVF and Fertility Department and demonstrating the growing capabilities of its specialty healthcare services.

    The Company continues to invest in advanced medical technologies, specialized clinical programs, and high-quality healthcare professionals to enhance patient outcomes and strengthen its reputation for clinical excellence.

    The Navi Mumbai and Nashik projects reflect Unihealth’s confidence in the long-term opportunities within India’s healthcare sector, which continues to benefit from increasing healthcare expenditure, expanding insurance coverage, demographic shifts, and growing demand for quality medical infrastructure.

    Commenting on the Company’s performance, Dr. Akshay Parmar, Founder & Managing Director, Unihealth Hospitals Limited, said: “FY26 marks a defining year in Unihealth’s growth journey. We delivered strong financial performance while simultaneously executing key strategic initiatives that significantly expanded our healthcare platform. Our ability to achieve robust revenue growth, improve profitability, and nearly double our bed capacity reflects the strength of our operating model, disciplined execution, and the trust patients place in our healthcare services.

    Our vision extends beyond operating hospitals. We are building a healthcare platform that combines clinical excellence, accessibility, innovation, and affordability. By leveraging our expertise across healthcare delivery, consultancy, pharmaceuticals, and medical value travel, we aim to create a sustainable ecosystem that improves healthcare outcomes while generating long-term value for all stakeholders.

    As we look ahead, our priorities remain centred on integrating and scaling our expanded network, progressing the Navi Mumbai and Nashik hospital projects, strengthening our healthcare offerings, and driving sustainable growth across all our operations. With a significantly larger capacity base, a strong presence across multiple geographies, and a clear expansion roadmap, we believe Unihealth is well-positioned to capitalize on the opportunities ahead and create long-term value for patients, communities, and shareholders.”

    Commenting on the outlook, Dr. Anurag Shah, Founder & Director, Unihealth Hospitals Limited, added:

    “Our FY26 performance demonstrates the resilience and scalability of the foundation we have built over the years. Alongside expansion, we have remained focused on operational excellence, resulting in meaningful improvements in profitability and efficiency. Rising patient volumes, a richer service mix, and disciplined cost management have all contributed to our strong performance.

    The successful acquisition of UMC Hospital, Entebbe, represents a transformational step in our evolution as a regional healthcare provider in Africa. Across East Africa, we continue to see significant unmet demand for quality healthcare infrastructure, specialized treatments, and advanced medical services. We believe these markets offer substantial long-term opportunities, and Unihealth is uniquely positioned to address them through its integrated healthcare ecosystem.

    Looking ahead, our focus will remain on maximizing utilization across our expanded network, integrating recent acquisitions, strengthening specialty healthcare services and expanding referral partnerships. With a larger operational footprint, enhanced capabilities, and a clear strategic roadmap, we are confident in our ability to sustain growth momentum and continue delivering high-quality healthcare to the communities we serve.”

    Growth Outlook

    Unihealth enters FY27 with strong momentum supported by:

    • Expanded healthcare infrastructure and increased capacity
    • Growing demand for quality healthcare services across India and East Africa
    • Strengthening specialty and tertiary care capabilities
    • Continued development of the Navi Mumbai and Nashik hospital projects
    • Increasing healthcare awareness and affordability in emerging markets
    • Opportunities to enhance operational efficiencies across the expanded network
    • A strong balance sheet and disciplined capital allocation strategy

    The Company remains committed to its mission of “Healthcare for All” and continues to pursue sustainable growth through strategic expansion, clinical excellence, innovation, and patient-centric care.

    About Unihealth Hospitals Limited

    Founded in Mumbai in 2010, Unihealth Hospitals Limited is an integrated healthcare platform focused on delivering affordable, accessible, and high-quality healthcare services across India and East Africa. The Company operates across multiple healthcare verticals, including hospital operations, healthcare consultancy, pharmaceutical and consumables exports, and medical value travel.

    Through the Unihealth–UMC Hospitals network, the Company combines Indian clinical expertise, global healthcare standards, and localized partnerships to create a scalable healthcare ecosystem serving diverse patient populations across emerging markets.

    Driven by its mission of “Healthcare for All,” Unihealth continues to expand its healthcare footprint while creating long-term value for patients, communities, healthcare professionals, and shareholders.

    The Company was listed on NSE Emerge in September 2023.

    For FY26, the Company reported consolidated Total Income of ₹137.01 Cr, EBITDA of ₹25.83 Cr, and Net Profit attributable to the equity shareholders of the Company of ₹25.83 Cr.

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • Back-to-Back Railway Wins: Magellanic Cloud Adds 7.64 Cr South Central Railway Contract to Surging 200 Cr Order Pipeline

    Back-to-Back Railway Wins: Magellanic Cloud Adds 7.64 Cr South Central Railway Contract to Surging 200 Cr Order Pipeline

    Hyderabad (Telangana) [India], June 1: Magellanic Cloud Ltd (NSE: MCLOUD | BSE: 538891), a global technology company specializing in digital transformation, artificial intelligence (AI), cloud computing, and surveillance solutions, announced that its wholly owned subsidiary, Provigil Surveillance Limited, has received a Letter of Acceptance (LOA) from South Central Railway, Nanded Division, for an aggregate contract value of approximately ₹7.64 Crore.

    The order pertains to the Provision of an IP-based video surveillance system at Stabling Lines, Washing Yards, and Pit Lines over the Nanded Division. The scope of the project includes supply, installation, testing, commissioning, and maintenance of IP-based CCTV surveillance systems along with networking infrastructure and a five-year Comprehensive Annual Maintenance Contract (CAMC).

    The project is scheduled to be executed over a period of 12 months and will contribute to Magellanic Cloud’s revenue recognition over the project period, including a five-year recurring maintenance stream post-commissioning. This win also adds to Magellanic Cloud’s expanding public sector e-surveillance order book, which exceeded 200 Crore during FY26. 

    The order further strengthens Magellanic Cloud’s positioning in the intelligent surveillance and public infrastructure solutions segment, supported by increasing investments in railway modernisation, digital infrastructure, and safety enhancement initiatives across India. South Central Railway spans over 6,100 route kilometres across Telangana, Andhra Pradesh, Maharashtra, and Karnataka, one of India’s busiest rail networks by freight and passenger traffic. The Nanded Division’s upgrade to IP-based surveillance directly supports the Ministry of Railways’ broader modernisation and safety enhancement agenda.

    Commenting on the order win, Mr. Joseph Sudheer Reddy Thumma, Chairman & Managing Director of Magellanic Cloud Limited, said: India’s railway modernization journey is creating significant opportunities for intelligent surveillance and infrastructure monitoring solutions. Nanded Division is strategically significant -it connects key freight and passenger corridors across Maharashtra and Telangana, and surveillance modernisation here has direct safety implications for thousands of rail operations daily. This is our 16th railway division over the last 12 months, and it reflects both the depth of trust Indian Railways has placed in Provigil and the repeatability of our deployment model. As our public sector order book crosses 200 Crore, we are focused on turning every project into a reference that wins the next ten. 

    The order not only reinforces our execution capabilities in large-scale surveillance deployments but also reflects the increasing adoption of technology-led safety and monitoring systems across public infrastructure. We remain focused on delivering scalable, reliable, and future-ready surveillance solutions that contribute to operational excellence and public safety.”

    About Magellanic Cloud Limited

    Magellanic Cloud Limited, headquartered in Hyderabad, India, is a global technology company specialising in digital transformation, Generative artificial intelligence (Al), cloud computing, e-surveillance, and drone technologies. The company Magellanic Cloud Limited, headquartered in Hyderabad, India, is a global technology company specialising in digital transformation, Generative artificial intelligence (Al), cloud computing, e-surveillance, and drone technologies.

    The company delivers advanced solutions across industries, including smart infrastructure, defence, fintech, and enterprise IT, serving over 100 clients across the USA, Europe, and Asia.

    With a strong ecosystem of subsidiaries such as Motivity Labs, Provigil Surveillance Limited, IVIS International, Scandron, and JNIT Technologies, Magellanic Cloud offers integrated capabilities across IT services and AI-driven surveillance systems. Its solutions are widely deployed in critical infrastructure projects, including railways, highways, and urban security systems, enabling enhanced safety, operational efficiency, and digital innovation.

    The company is backed by a team of over 1,600 professionals and emphasizes innovation-led growth through investments in AI, analytics, and cloud technologies. With a focus on process excellence, Magellanic Cloud has achieved CMMI Maturity Level 3 certification, reinforcing its ability to deliver consistent, high-quality solutions aligned with global standards.

    For FY26, the company reported consolidated total income of 706.78 Cr, with an EBITDA of 224.30 Cr and a PAT of 114.39 Cr.

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • CASHurDRIVE Continues Winning Momentum with Back-to-Back Business Mandates

    CASHurDRIVE Continues Winning Momentum with Back-to-Back Business Mandates

    Noida (Uttar Pradesh) [India], June 1: Cash Ur Drive Marketing Limited (NSE: CUDML | INE0WL201014), a leading transit media and mobility solutions company, has announced the receipt of multiple business mandates across advertising and mobility-related services. The developments reflect the Company’s continued business momentum and strengthen revenue visibility through a combination of long-term and short-duration engagements.

    Key Business Updates

    • 10-Year EV Charging Station Mandate Awarded: Received an LoA for the establishment, operation, and maintenance of EV Charging Stations. Commissioning is scheduled within 90 days from site handover, followed by a 10-year O&M period.
    • ₹3.29 Crore Outdoor Advertising Order Secured: Received a work order for the execution of outdoor advertising campaigns across multiple locations in India. The campaign is scheduled for execution within one month.
    • ₹2.12 Crore OOH Advertising Order from Leading Mobility Platform: Received a purchase order for Out-of-Home (OOH) advertising services from a leading multinational mobility and technology platform company. Execution is expected to be completed within 40 days.

    Together, these engagements provide a blend of long-term operational visibility and near-term execution opportunities, while further strengthening the Company’s business pipeline and client portfolio.

    Commenting on order win, Mr. Raghu Khanna, Managing Director and Chairman, Cash Ur Drive Marketing Limited, said: “The diverse nature of these mandates highlights the opportunities emerging across both media and mobility-linked services. As we continue to strengthen our order pipeline, our focus remains on execution, client relationships, and building a scalable business platform that supports long-term growth.”

    About CashUrDrive Marketing Limited

    Founded in 2009, CashUrDrive Marketing Limited (“CUD” or “the Company”) is one of India’s fastest-growing out-of-home and transit media companies, pioneering sustainable and technology-driven advertising solutions. With a strong presence across major cities, CUD integrates transit, digital, outdoor, and green media assets to deliver impactful visibility for leading brands. The Company’s focus on innovation, exclusive media rights, and expansion into EV charging station advertising has positioned it as a new-age leader in the evolving media landscape. Guided by a vision to make advertising more effective, eco-friendly, and inclusive, CUD continues to redefine how brands connect with audiences on the move. 

    For FY26, the Company reported a Total Income of ₹192.38 crore, EBITDA of ₹39.29 crore, and Net Profit of ₹29.40 crore.

    The company got listed on NSE Emerge in August, 2025.

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • Dev IT Reports Strong FY26 with Enhanced Digital Capabilities, Strategic Partnerships, and Expanding Growth Pipeline

    Dev IT Reports Strong FY26 with Enhanced Digital Capabilities, Strategic Partnerships, and Expanding Growth Pipeline

    Ahmedabad (Gujarat) [India], June 1: Dev Information Technology Limited (DEV IT), (NSE – DEVIT, BSE – 543462 | INE060X01034), a global IT services company offering Cloud Services, Digital Transformation, Enterprise Applications, and Managed IT Services, has reported its Audited financials for Q4 FY26 & FY26.

    Key Standalone Financial Highlights

    Q4 FY26 Standalone Key Financial Highlights

    • Total Income of ₹48.16 Cr, YoY growth of 4.28%
    • EBITDA of ₹4.07 Cr, YoY growth of 93.38%
    • EBITDA Margin of 8.45%, YoY growth of 389 Bps
    • Net Profit of ₹8.27 Cr, YoY growth of 848.70%
    • Net Profit Margin of 17.16%, YoY growth of 1,528 Bps
    • Diluted EPS of ₹1.44, YoY growth of 860.00%

    FY26 Standalone Key Financial Highlights

    • Total Income of ₹165.42 Cr, YoY growth of 1.29%
    • EBITDA of ₹5.39 Cr
    • EBITDA Margin of 3.26%
    • Net Profit of ₹74.24 Cr, YoY growth of 381.44%
    • Net Profit Margin of 44.88%, YoY growth of 3,544 Bps
    • Diluted EPS of ₹13.02, YoY growth of 375.18%

    *Includes Exceptional Unrealised gain of ~92.36 crore on reclassification of EV Accelerator stake post IPO

    Key Consolidated Financial Highlights

    Q4 FY26 Consolidated Key Financial Highlights

    • Total Income of ₹56.00 Cr, YoY growth of 8.14%
    • EBITDA of ₹5.04 Cr, YoY growth of 68.53%
    • EBITDA Margin of 8.99%, YoY growth of 322 Bps
    • Net Profit of ₹8.96 Cr, YoY growth of 689.42%
    • Net Profit Margin of 15.99%, YoY growth of 1,380 Bps
    • Diluted EPS of ₹1.56, YoY growth of 642.86%

    FY26 Consolidated Key Financial Highlights

    • Total Income of ₹193.50 Cr, YoY growth of 5.21%
    • EBITDA of ₹7.23 Cr
    • EBITDA Margin of 3.74%
    • Net Profit of ₹75.60 Cr, YoY growth of 411.48%
    • Net Profit Margin of 39.07%, YoY growth of 3,103 Bps
    • Diluted EPS of ₹13.25, YoY growth of 401.89%

    *Includes Exceptional Unrealised gain of ~93.55 crore on reclassification of EV Accelerator stake post IPO

    Recent Key Business Highlights

    Strategic Partnerships & Expansion
     
     
    XDuce acquired ~24% strategic stake in DEV IT to strengthen AI, cybersecurity and global presenceSigns Exclusive Master Distribution Agreement with A21 Technologies to Scale their AI-powered product “Talligence” Across IndiaAchieved all six Microsoft Solutions Partner Designations across in conjunction with its wholly owned subsidiary, Dhyey Consulting Services Pvt. Ltd.
     
     
    Business Restructuring & Corporate Developments Approved the transfer of its product businesses, ByteSIGNER and Talligence, to Byte Technosys Private Limited, an associate company in ₹11.90 Cr transaction cash consideration.Approved ESOP allotment of 28,482 equity shares

    Commenting on the Financial Performance, Mr. Pranav Pandya, Chairman, Dev Information Technology Limited, said: “FY26 was a strategically significant year for Dev Information Technology as we strengthened our position across cloud services, digital transformation, enterprise applications, and managed IT services while simultaneously enhancing operational efficiency and profitability. Our growth was supported by strong execution, higher value service engagements, and continued focus on delivering integrated technology solutions to enterprise customers.

    During the year, we completed several key strategic initiatives that will strengthen our long-term growth prospects. The acquisition of a strategic stake by XDUce has created opportunities to enhance our AI, cybersecurity, and global delivery capabilities, while our collaboration with A2I Technologies expands our presence in AI-powered product offerings. In addition, our achievements across Microsoft solution partner designations reinforce our technical capabilities and deepen our ability to address evolving customer requirements.

    We also took decisive steps to sharpen our business focus through the transfer of certain product businesses and portfolio optimization initiatives, enabling greater resource allocation toward scalable and higher-growth opportunities. These actions, combined with our strong customer relationships and expanding service capabilities, have improved our operating leverage and strengthened the foundation for future growth.

    About Dev Information Technology Limited

    Dev Information Technology Limited (DEV IT), founded in 1997, listed on NSE & BSE, and certified to ISO 20000, ISO 27001, ISO 9001 & CMMI Level 5, has evolved from a small-scale business automation software solutions provider into a global IT services powerhouse. Over the years, the company has empowered businesses worldwide with a blend of information technology, innovation, and digital transformation. Headquartered in Ahmedabad, with offices across India and Canada, the company emphasises continuous innovation, quality, streamlined processes, and technological prowess. The company’s people- and client-centric approach involves collaborating with clients globally to understand their specific goals and to empower them to achieve their business objectives. 

    The company offers a comprehensive end-to-end range of services, including Cloud Services, Digital Transformation, Enterprise Applications, Managed IT Services, and Application Development. The company’s products comprise Talligence, an accounting data analytics platform, and ByteSigner, a digital signing solution.

    With its foundation in one of India’s fastest-growing metros, the company has continuously evolved to meet the dynamic demands of the IT industry. The leadership, comprising experienced professionals, drives the company towards achieving its vision of empowering businesses worldwide through cutting-edge technology solutions. The company’s steadfast commitment to innovation, quality, and client satisfaction underpins its growth and success in the IT services sector. 

    In conclusion, the company remains dedicated to driving digital transformation and delivering unparalleled value to its clients. As the company moves forward, it continues to embrace new challenges and opportunities, solidifying its position as a leader in the IT services sector. Visit www.devitpl.com for more information.

    In Consolidated FY26, the company reported Total Income of ₹193.50, EBITDA of ₹7.23, and Net Profit of ₹75.60. Looking ahead, demand for cloud adoption, AI-led transformation, cybersecurity, and managed services continues to remain strong across industries. With an expanded solutions portfolio, stronger strategic partnerships, improved operational efficiencies, and a growing pipeline of opportunities, we are entering FY27 with confidence and remain focused on delivering sustainable growth, margin enhancement, and long-term value creation for all stakeholders.”

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • Sandeep Marwah Honoured with Prestigious Literature Award in Sydney

    Sandeep Marwah Honoured with Prestigious Literature Award in Sydney

    Sydney [Australia], June 01: In a grand and inspiring gathering of distinguished literary personalities, community leaders, artists, and members of the Indian diaspora, Dr. Sandeep Marwah, Founder of AAFT and President of ICMEI, was honoured with the prestigious Literature Award by the Indian Literary and Art Society of Australia (ILASA Inc.) in recognition of his remarkable four-decade-long contribution to creative arts, culture, media, education, and literature.

    The award was conferred in appreciation of Dr. Marwah’s visionary efforts in promoting literary and cultural exchange globally and for establishing the Global Literary Festival Noida, which has grown into one of the largest academic literary festivals in the world and has been successfully organized for the past twelve years.

    The prestigious honour was presented by renowned literary figure and AAFT alumnus Dr. Rekha Rajvanshi, along with members of ILASA Inc., during an elegant ceremony attended by eminent personalities from Australia’s literary, cultural, and business communities.

    Speaking on the occasion, Dr. Rekha Rajvanshi lauded Dr. Marwah’s relentless dedication to strengthening cultural diplomacy and creating meaningful platforms that connect writers, artists, intellectuals, and creative professionals across nations. She emphasized that his contribution to literature, art, media, and education has inspired thousands of people around the world.

    Expressing his gratitude, Dr. Sandeep Marwah reflected on his journey of over forty years devoted to media, arts, culture, education, and social development. He highlighted the vital role of literature and cultural exchange in fostering mutual understanding among nations and thanked ILASA Inc. for the honour and recognition.

    The ceremony was graced by several distinguished guests including Sameer Pandey, Lord Mayor; Alok Rajvanshi, former Captain of the Merchant Navy; Yogesh K. Sharma, Managing Director of Cinestar Events; Bipen Sharma, Founder and Chairman of GPS Investments Ltd. and Sharma’s Kitchens; Arun Bose, owner of the renowned Kashi Restaurant; Anurag Sharma, General Manager of Holiday Inn Parramatta; Harmohan Walia, President of GOPIO and a passionate photographer; Praveen Sharma, known for promoting spiritual and cultural initiatives; Srijani Ghosh, singer and Director of Heritage Harmony Music; acclaimed actor Simran Gulati; and Ashish Gulati, along with many respected members of the literary and cultural fraternity.

    The distinguished gathering highly appreciated Dr. Marwah’s extraordinary achievements in promoting Indian culture, literature, education, media, and international relations through numerous global initiatives. The event provided a unique platform for interaction among writers, artists, entrepreneurs, and community leaders committed to strengthening cultural cooperation between India and Australia.

    The ceremony concluded on a positive and forward-looking note with a renewed commitment to enhancing literary and cultural ties between the two nations and encouraging greater collaboration among creative communities worldwide. The occasion also celebrated the enduring power of literature and culture in bringing people, ideas, and nations closer together.

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • IMS Ghaziabad Organizes Guest Talk on Modern Marketing Trends for BBA First-Year Students

    IMS Ghaziabad Organizes Guest Talk on Modern Marketing Trends for BBA First-Year Students

    New Delhi [India], June 01: Reinforcing its commitment to bridging academic learning with industry exposure, the Department of Management at IMS Ghaziabad (University Courses Campus) recently organized an insightful Guest Talk Session for BBA First-Year students (Batch 2025–28). The session featured Mr. Devansh Gill, Solutions and Strategy Manager at The Brand Brew, who shared valuable industry perspectives on the evolving landscape of modern marketing.

    The guest lecture was designed to help students understand how theoretical marketing concepts align with real-world business practices. During the session, Mr. Gill highlighted the rapidly changing nature of marketing and how businesses today are leveraging innovation, technology, and strategic communication to engage consumers effectively.

    Addressing the students, he elaborated on emerging marketing practices, the role of branding agencies, social media influence, digital transformation, and evolving consumer behavior in India. He also emphasized the importance of adaptability, creativity, and data-driven decision-making in building strong and impactful brand identities in today’s competitive marketplace.

    The interactive session provided students with practical insights into how brands are created, managed, and adapted according to market demands and consumer expectations. Through real-world examples and industry-backed observations, students gained a deeper understanding of the challenges and opportunities in the marketing ecosystem.

    Faculty members from the Department of Management highlighted that such guest talks play a vital role in enriching classroom learning by exposing students to real industry scenarios and professional expertise. IMS Ghaziabad continues to focus on holistic education by creating opportunities where students can interact with experienced industry leaders and develop skills aligned with future career demands.

    Speaking on the success of the event, the institution stated that the session effectively connected academic theory with practical applications, encouraging students to think critically about branding, consumer engagement, and the future of marketing in India.

    This engaging guest talk once again reflected IMS Ghaziabad’s dedication to empowering students with industry-relevant knowledge, experiential learning, and practical exposure beyond traditional academics.

    About IMS Ghaziabad (University Courses Campus)

    IMS Ghaziabad (University Courses Campus) is one of the leading educational institutions committed to academic excellence, innovation, and industry-oriented learning. Through expert sessions, workshops, and experiential initiatives, the institution consistently prepares students to thrive in dynamic professional environments.

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

  • Cordlife India’s “Save The Sibling” Initiative Brings New Hope for Thalassemia Families

    Cordlife India’s “Save The Sibling” Initiative Brings New Hope for Thalassemia Families

    New Delhi [India], June 01: Cordlife India’s “Save The Sibling” initiative is giving new hope to families affected by thalassemia. Conceived and supported by Cordlife India, the project was launched on 14 November 2022 with the aim of helping children suffering from severe thalassemia through advanced stem cell treatment.

    The first successful case under this program was completed on 16 October 2025. The treatment involved a 7-year-old boy, Akshoy Sarker Dhrubo, who was suffering from Hb E beta-thalassemia, a severe blood disorder. Since childhood, he depended on regular blood transfusions to survive. Frequent transfusions also caused dangerous iron overload in his body.

    Doctors could not find a fully matched stem cell donor within the family. To overcome this challenge, the family underwent a special IVF procedure with advanced genetic testing under the guidance of Dr. Rajeev Agarwal and his team. The process ensured that the newborn baby would be healthy and a perfect stem cell match for the elder brother.

    After the birth of baby Aradhya, stem cells were collected from the newborn’s umbilical cord blood and safely cryogenically preserved through Cordlife India, highlighting the potential of cord blood banking in supporting life-saving treatments. The child’s mother, Mrs. Madhabi Rani, also donated stem cells as a half-matched donor under the treatment of Dr. Joydeep Chakrabarty and his medical team.

    Doctors then performed a combined stem cell transplant using both the mother’s stem cells and the newborn sibling’s cord blood stem cells. After treatment and careful medical care, the child recovered successfully. He no longer needs blood transfusions and is now stable and healthy.

    A significant part of the IVF, cord blood preservation, and transplantation expenses was facilitated through support extended under Cordlife India’s “Save The Sibling” initiative.

    This successful outcome highlights the growing importance of stem cell banking and the potential of preserved cord blood in supporting life-saving treatments. It also underscores how preserving a newborn’s stem cells with Cordlife today can serve as a valuable biological resource for the future, offering families access to advanced therapeutic options when they may need them most.

    For more information: Dr. Prosanto Chowdhury- 9830055287

    visit: https://www.cordlifeindia.com

     https://www.facebook.com/CordlifeIndia

     https://www.instagram.com/cordlife_india/

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.